J&J Hip Replacement Recall
According to the Associated Press, Johnson & Johnson is recalling two hip replacement products after it emerged that a significant number of patients implanted with devices, required revision surgery to correct problems with the “fit” of the artificial joints. DePuy Orthopaedics Inc, a subsidiary of Johnson & Johnson, has announced that it is recalling both the ASR Hip Resurfacing System and the ASR XL Acetabular System. Clinical data released by the British-based National Joint Registry of England and Wales, recently revealed that between 12 and 13 percent of patients receiving the ASR Hip Resurfacing System and/or the ASR XL Acetabular System would need corrective surgery within five years. The generally accepted standard for such revisions within five years of the surgery is no more than 5% of patients. The study also revealed that the women were at greater risk than men.
DePuy and its parent company Johnson and Johnson have been hit with a number of high profile recalls in recent months. Earlier this week, the Food and Drug Administration (FDA) ordered DePuy to withdraw its Corail Hip System from sale after it emerged that the company had been marketing the product for unapproved uses.
If you or a loved one has experienced serious pain or required corrective surgery following either an ASR Hip Resurfacing System or an ASR XL Acetabular System implant, you may be entitled to compensation. Call Burg Simpson’s dangerous medical device attorneys toll-free on 1.888.895.8020 for a free consultation.
